Klinické studie - neví se
Belotecan
- Camptothecin analogue
Phase II trials
Phase III trial comparing EP with cisplatin/belotecan in patients with previously untreated ES-SCLC is running in Asia
Ipilimumab-nivolumab
- In pre-frontline immunotherapy stratus had some data for efficacy
- www.onclive.com/view/treatment-options-for-relapsed-small-cell-lung-cancer
Jared Weiss, MD: Less than that: once or less than once a year.
Obatoclax
- A Bcl-2 inhibitor
Phase I/II trials including patients with SCLC
Bevacizumab
- A monoclonal antibody that binds vascular endothelial growth factor (VEGF)
- Treatment of advanced-stage NSCLC
- Evaluated in SCLC
- Two cooperative group phase II trials evaluating the use of bevacizumab in the treatment of ES-SCLC are pending
- erj.ersjournals.com/content/35/1/202